Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E6 protein is an oncogenic protein encoded by the human papillomavirus type 18 (HPV-18) genome. It plays a central role in HPV-induced cellular transformation and is directly implicated in the development of cervical cancer and other HPV-related malignancies. E6 acts primarily by degrading the tumor suppressor p53, activating telomerase, and modulating the immune response. It interacts with host cell proteins, including E6AP, to achieve these functions.
Recruits E6AP ubiquitin ligase to degrade p53; activates hTERT to increase telomerase activity; inhibits interferon signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 18 E6 Protein.